By Joel White | Real Clear Health
Some breathless Beltway pundits would have you believe corporate America is at war with itself over the Build Back Better Act, President Biden’s ungainly multi-trillion-dollar grab bag of a budget bill.
“Big business lobbies bitterly divided over drug pricing reform,” blared one recent headline.
It’s a juicy narrative — but baseless. The notion that businesses are divided comes from skillful media relations on the part of two relatively small trade associations — the ERISA Industry Committee (ERIC) and the Purchaser Business Group on Health (PBGH). Both, it’s true, favor price-control legislation included in the broader budget bill…Read More Here>>